Knight Therapeutics Inc.

TSX:GUD.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$11.56 +0.75%

+$0.07 today

Market cap
$1.14B
Beta
0.07
P/E (TTM)
164.6
EPS (TTM)
$0.06
52W Low $5.66High $9.59

Volume 0.04M

Average 0.10M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.05B

FY 2025 · Annual

+8.6% YoY

Liabilities

$279.03M

FY 2025 · Annual

+65.4% YoY

Equity

$767.27M

FY 2025 · Annual

-3.5% YoY

Balance Sheet

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents85.96M71.68M58.76M80.11M76.45M
Short-term Investments77.03M119.54M95.66M92.73M18.83M
Net Receivables67.41M108.57M98.23M113.53M138.24M
Inventory72.4M92.49M91.83M102.7M135.87M
Other Current Assets2.35M19.29M15.75M14.02M18.95M
Total Current Assets307.32M395.62M365.12M396.81M394.84M
Property, Plant & Equipment (Net)29.94M22.63M17.86M20.02M21.93M
Goodwill75.4M82.27M79.84M86.48M89.98M
Intangible Assets350.3M338.78M289.96M283.61M379.51M
Long-term Investments178.95M158.02M120.02M103.43M124.24M
Tax Assets2.05M9.31M19.39M21.25M26.92M
Other Non-current Assets47.93M48.2M53.3M52.2M8.88M
Total Non-current Assets684.57M659.22M580.38M566.98M651.46M
Total Assets991.89M1.05B945.49M963.8M1.05B
Account Payables65.31M106.06M85.37M78.35M120.87M
Short-term Debt26.66M17.67M17.85M17.49M20.13M
Tax Payables7.07M2.27M1.18M213K0
Deferred Revenue9.73M0000
Other Current Liabilities1.99M15.01M7.9M1.88M20.29M
Total Current Liabilities105.3M141.32M114.03M111.25M165.26M
Long-term Debt9.27M52.4M44.02M25.9M51.17M
Deferred Tax Liabilities12.37M4.37M2.82M3.84M2.99M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities19.52M25.85M32.26M24.27M52.99M
Total Non-current Liabilities44.57M87.66M84.59M57.44M113.77M
Total Liabilities149.87M228.98M198.62M168.69M279.03M
Common Stock628.85M599.06M540.05M534.27M530.14M
Retained Earnings191.65M161.76M150.89M154.79M148.94M
Accumulated OCI(259K)41.38M29.95M80.22M55.74M
Other Stockholders Equity000117K0
Minority Interest00000
Total Equity842.02M825.86M746.87M795.11M767.27M
Total Debt40.96M77.7M69.09M49.46M77.91M
Net Debt(45.01M)6.02M10.33M(30.65M)1.46M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$108.0M
Short-term Investments$19.2M
Receivables$156.6M
Inventory$141.9M
Other Current$21.1M
Total Current Assets$447.0M
PP&E (Net)$30.4M
Goodwill$95.3M
Intangible Assets$354.0M
Long-term Investments$123.7M
Tax Assets$26.7M
Other Non-current$9.5M
Total Non-current Assets$639.6M
Total Assets$1.1B

Analysis

Selected assets total $1.1B for Latest. The largest visible component is Intangible Assets at $354.0M, about 32.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

No filings found.

How much cash does GUD.TO have?

Knight Therapeutics Inc. (GUD.TO) reported $76.45M in cash and equivalents in fiscal 2025.

How much debt does GUD.TO carry?

Knight Therapeutics Inc. (GUD.TO) reported $77.91M of total debt, with net debt of $1.46M.